Stock-Based Compensation

$34.64M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$34.64Mperiod endingJun 30, 2026

CLDX Stock-Based Comp ($0.00 → $34.64M)

Annual stock-based compensation

High-resolution chart · PNG

CLDX stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	36,217,000
Dec 31, 2024	34,242,000
Dec 31, 2023	23,890,000
Dec 31, 2022	0
Dec 31, 2021	8,953,000
Dec 31, 2020	3,915,000
Dec 31, 2019	4,551,000
Dec 31, 2018	8,081,000
Dec 31, 2017	12,312,000
Dec 31, 2016	15,317,000
Dec 31, 2015	12,774,000
Dec 31, 2014	6,852,000
Dec 31, 2013	4,548,000
Dec 31, 2012	2,298,000
Dec 31, 2011	2,342,000
Dec 31, 2010	2,802,000
Dec 31, 2009	3,058,000
Dec 31, 2008	4,815,693,000
Dec 31, 2007	359,543,000
Dec 31, 2006	1,626,756,000
Dec 31, 2005	538,000,000
Dec 31, 2004	328,000,000
Dec 31, 2003	115,000,000
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Apr 30, 1992	0
Apr 30, 1990	0
Apr 30, 1989	0
Apr 30, 1988	0
Apr 30, 1987	0